Feasibility and validation of trans-valvular flow derived by four-dimensional flow cardiovascular magnetic resonance imaging in pacemaker recipients
- PMID: 32889092
- PMCID: PMC7674584
- DOI: 10.1016/j.mri.2020.08.024
Feasibility and validation of trans-valvular flow derived by four-dimensional flow cardiovascular magnetic resonance imaging in pacemaker recipients
Figures






References
-
- Raatikainen M.J.P., Arnar D.O., Merkely B. A decade of information on the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2017 report from the European Heart Rhythm Association. Europace. 2017;19(suppl_2):ii1–ii90. - PubMed
-
- Brignole M., Auricchio A., Baron-Esquivias G. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA) Eur Heart J. 2013;34(29):2281–2329. - PubMed
-
- Bhuva A.N., Kellman P., Graham A. Clinical impact of cardiovascular magnetic resonance with optimized myocardial scar detection in patients with cardiac implantable devices. Int J Cardiol. 2019;279:72–78. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources